Start-ups: Clinical trials - This AI company wants to lower the most expensive hurdle in the pharmaceutical industry
The company Atlas Bio is improving the success rate of clinical trials, which so far have seen 70 percent of all drugs fail. To do this, the start-up is now raising $11 million.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.